U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H16N4O3S
Molecular Weight 368.41
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of VE-821

SMILES

CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(N)C(=N2)C(=O)NC3=CC=CC=C3

InChI

InChIKey=DUIHHZKTCSNTGM-UHFFFAOYSA-N
InChI=1S/C18H16N4O3S/c1-26(24,25)14-9-7-12(8-10-14)15-11-20-17(19)16(22-15)18(23)21-13-5-3-2-4-6-13/h2-11H,1H3,(H2,19,20)(H,21,23)

HIDE SMILES / InChI

Molecular Formula C18H16N4O3S
Molecular Weight 368.41
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/22825331

VE-821 is a potent ATP-competitive inhibitor of ATR (Ki of 13nM). VE-821 shows excellent selectivity for ATR with minimal cross-reactivity against the related PIKKs ATM, DNA-dependent protein kinase (DNA-PK), mammalian target of rapamycin and phosphoinositol 3-kinase-γ (Ki s of 16 uM, 2.2 uM, >1 uM and 3.9 uM, respectively) and against a large panel of unrelated protein kinases. VE-821 has being shown to increase sensitivity of pancreatic cancer cells to radiation and chemotherapy.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
13.0 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
VE-821 (2 and 10 uM) reduced the number of irradiated HL-60 cells in the G2 phase to the level of non-irradiated cells and increased the number of irradiated cells in S phase, compared to irradiated cells not treated with inhibitors.
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:14:25 GMT 2023
Edited
by admin
on Sat Dec 16 16:14:25 GMT 2023
Record UNII
BF884TQ935
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
VE-821
Code English
3-AMINO-6-(4-(METHYLSULFONYL)PHENYL)-N-PHENYL-2-PYRAZINECARBOXAMIDE
Systematic Name English
2-PYRAZINECARBOXAMIDE, 3-AMINO-6-(4-(METHYLSULFONYL)PHENYL)-N-PHENYL-
Systematic Name English
3-AMINO-6-(4-(METHYLSULFONYL)PHENYL)-N-PHENYLPYRAZINE-2-CARBOXAMIDE
Common Name English
3-AZANYL-6-(4-METHYLSULFONYLPHENYL)-N-PHENYL-PYRAZINE-2-CARBOXAMIDE
Systematic Name English
Code System Code Type Description
CAS
1232410-49-9
Created by admin on Sat Dec 16 16:14:25 GMT 2023 , Edited by admin on Sat Dec 16 16:14:25 GMT 2023
PRIMARY
EPA CompTox
DTXSID60679574
Created by admin on Sat Dec 16 16:14:25 GMT 2023 , Edited by admin on Sat Dec 16 16:14:25 GMT 2023
PRIMARY
FDA UNII
BF884TQ935
Created by admin on Sat Dec 16 16:14:25 GMT 2023 , Edited by admin on Sat Dec 16 16:14:25 GMT 2023
PRIMARY
PUBCHEM
51000408
Created by admin on Sat Dec 16 16:14:25 GMT 2023 , Edited by admin on Sat Dec 16 16:14:25 GMT 2023
PRIMARY